Suchitrita S. Rathmann

Efficacy and safety of ascending methotrexate dose in combination with adalimumab: the randomised CONCERTO trial

Gerd‐Rüdiger Burmester, Alan Kivitz, H. Küpper et al. · Annals of the Rheumatic Diseases · 2014 · 228 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and Safety of Ixekizumab in Patients with Active Psoriatic Arthritis: 52-week Results from a Phase III Study (SPIRIT-P1)

Désirée van der Heijde, Dafna D. Gladman, Mitsumasa Kishimoto et al. · The Journal of Rheumatology · 2017 · 123 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Spinal Inflammation in the Absence of Sacroiliac Joint Inflammation on Magnetic Resonance Imaging in Patients With Active Nonradiographic Axial Spondyloarthritis

Désirée van der Heijde, Joachim Sieper, Walter P. Maksymowych et al. · Arthritis & Rheumatology · 2013 · 77 citations · Full text

Medicine, Radiology, Diagnostic Imaging +15

Maintenance of improvement in spinal mobility, physical function and quality of life in patients with ankylosing spondylitis after 5 years in a clinical trial of adalimumab

Désirée van der Heijde, Maxime Bréban, D Halter et al. · Lara D. Veeken · 2014 · 56 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +13

Ixekizumab treatment of biologic-naïve patients with active psoriatic arthritis: 3-year results from a phase III clinical trial (SPIRIT-P1)

Vinod Chandran, Désirée van der Heijde, Roy Fleischmann et al. · Lara D. Veeken · 2020 · 54 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +12